T 2342/16 (Stable protein formulations/BMS) of 11.02.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T234216.20200211
- Date of decision
- 11 February 2020
- Case number
- T 2342/16
- Online on
- 3 April 2020
- Petition for review of
- -
- Application number
- 06846683.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- STABLE PROTEIN FORMULATIONS
- Applicant name
- Bristol-Myers Squibb Company
- Opponent name
- D Young & Co LLP
Potter Clarkson LLP
ISENBRUCK BÖSL HÖRSCHLER LLP - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 56
- Keywords
- Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0209/25
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain a patent on the basis of the main request filed on 3 June 2016 and a description to be adapted thereto.